GPCR Therapeutics launches multiple myeloma trial
GPCR Therapeutics, Inc., a drug discovery company targeting G Protein Coupled Receptors (GPCR) pairs, has…
January 19, 2023 - 2 minutes
Multiple myeloma
Janssen looks for talquetamab marketing approval
The Janssen Pharmaceutical Companies of Johnson & Johnson has submitted a marketing authorisation application (MAA)…
January 3, 2023 - 2 minutes
Legend Biotech new drug application approved in China
Legend Biotech Corporation has announced that China’s National Medical Products Administration (NMPA) has formally accepted…
January 3, 2023 - 3 minutes
Step Pharma announces promising pre-clinical cancer data
Step Pharma has announced encouraging pre-clinical data on its first-in-class, highly selective, orally bioavailable CTPS1…
December 12, 2022 - 2 minutes
MIF invests in KAHR to explore lead immunotherapy drug for multiple myeloma
KAHR Medical, a clinical stage biotech company that is developing a treatment for solid tumors…
November 18, 2022 - 3 minutes
Oncopeptides starts European commercialization of myeloma drug in Germany
Swedish biotech company Oncopeptides AB has initiated the commercial launch of Pepaxti (melphalan flufenamide) in…
October 3, 2022 - 2 minutes
Knockback for drug to treat patients with relapsed or refractory multiple myeloma
A Swedish biotech company says it believes its treatment could be the ‘canary in the…
September 23, 2022 - 3 minutes
Collaboration to explore gene therapy products for neurodegenerative disorders
Coave Therapeutics is collaborating with the Institute of Neurodegenerative Diseases (IMN) of Bordeaux to develop…
September 14, 2022 - 3 minutes
Update: US District Court Rules Against MorphoSys’ Cancer Immunotherapy Patents
Update (01/02/2019): MorphoSys has agreed to end its long-running legal battle with Genmab and Janssen, after…
January 28, 2019 - 3 minutes
Genmab and Janssen Suffer Combination Therapy Setback
Janssen will discontinue a Phase I study testing Danish biotech Genmab's blood cancer blockbuster daratumumab…
May 28, 2018 - 2 minutes
Smile! Here are the 12 Biggest Biotech Clinical Successes of 2017
Now that we've got the bad news out of the way, we're here to spread…
December 18, 2017 - 9 minutes
Welcome to the Blockbuster Club, Genmab!
Genmab has achieved $1B sales in the US of its blood cancer drug, Darzalex, setting a…
November 17, 2017 - 3 minutes
